RxDoctor Payments Data

Diane Joy Zaragoza, MD

Family Medicine · Veedersburg, INNPI 1720217466

Payments from drug & device makers

$511in general payments, 2019–2025

Across 37 payments — averaging $13.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$76
  • Johnson & Johnson$65
  • Novo Nordisk$52
  • Pfizer$51
  • Astellas Pharma US Inc$49
  • Lilly USA, LLC$48
  • plus $169 from 8 others

What the payments were for

  • Food & beverage$49998%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$511 in reported general payments places this provider in the 50th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$38,157
Medicare patients
180
Services billed
460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban249$207,975
OzempicSemaglutide146$184,268
TrulicityDulaglutide110$104,906
Cosentyx Sensoready (2 Pens)Secukinumab12$82,377
XareltoRivaroxaban83$71,623
JardianceEmpagliflozin73$64,854
Trelegy ElliptaFluticasone/Umeclidin/Vilanter80$63,815
JanuviaSitagliptin Phosphate38$35,022
FarxigaDapagliflozin Propanediol24$33,676
RexultiBrexpiprazole21$30,025
MounjaroTirzepatide23$28,441
TradjentaLinagliptin28$28,153
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr52$28,069
LinzessLinaclotide37$22,453
Spiriva RespimatTiotropium Bromide30$19,609

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$51$207,975249 claims
Novo NordiskOzempic$52$184,268146 claims
Lilly USA, LLCTrulicity, Mounjaro$48$133,348133 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat, Combivent Respimat, Synjardy Xr$14$131,583167 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$12$106,335168 claims
Johnson & JohnsonXarelto$65$71,62383 claims
AstraZenecaFarxiga, Symbicort$76$44,82955 claims
Astellas Pharma US IncMyrbetriq$49$15,84231 claims
NovartisEntresto$24$7,75312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Veedersburg

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →